2026-04-15T13:23:38-04:00 / 福克斯新闻频道
这项拟议新规将要求全面披露隐藏费用与利益冲突
作者：安德鲁·马克·米勒、基拉·麦克唐纳 福克斯新闻
发布时间：2026年4月15日 美国东部时间下午1:23
白宫反欺诈工作组发现63亿美元潜在政府欺诈资金
白宫反欺诈工作组副主席安德鲁·弗格森谈及该工作组发现63亿美元潜在欺诈性政府合同，批评民主党州长数十年来任由大规模欺诈泛滥甚至助长欺诈行为。弗格森披露了涉嫌欺诈者奢侈挥霍的案例，并指出加州和夏威夷等州在收到联邦资金后仍未能起诉欺诈行为。
【新增功能】您现在可以收听福克斯新闻文章！
收听本文
5分钟
【福克斯新闻独家报道】 12个州的财务官员正支持美国劳工部一项针对医疗保健“中间商”的拟议规则，要求提高透明度，他们对特朗普政府打击浪费、欺诈和滥用职权的行动以及降低医疗成本的目标表示支持。
在福克斯新闻数字频道获得的致劳工部的信件中，州财务官员协会（SFOF）的十余名州财务官员对劳工部正在审议的一项针对药品福利管理机构（PBMs）的拟议规则表示支持，该规则将揭露推高成本的隐藏费用、利益冲突和超额收费行为。
“医疗采购方一直在黑暗中运作，由于定价不透明和中间商掩盖每笔资金的流向，我们支付了虚高的成本，”州财务官员基金会首席执行官OJ·奥莱卡对福克斯新闻数字频道表示。“通过将这些隐藏的定价公之于众，企业终于可以识别浪费、协商更优惠的交易，并将节省下来的资金用于提高工资、创造更多就业岗位、为员工提供更优厚的福利，以及提升股东价值。”
奥莱卡进一步解释称，从州层面来看，新规则带来的透明度“对于保障纳税人资源、履行受托责任至关重要”。
劳工部针对210亿美元失业救济金债务及欺诈问题向加州部署‘突击小组’
2026年4月11日，美国总统唐纳德·特朗普在佛罗里达州迈阿密国际机场走出空军一号后向媒体挥手。（塔索斯·卡托波迪斯/盖蒂图片社摄）
“透明度不仅关乎问责制；它对于检测浪费、防范欺诈，以及确保医疗支出最终为承担这些成本的劳动者、企业和纳税人带来价值，都至关重要。”
如果该规则得以实施，将要求全面披露这些“中间商”的收入来源，监管范围将从药品福利管理机构扩大到保险公司和第三方管理人，并允许获取索赔和定价数据。州财务官员协会表示，这将成为打击欺诈的关键工具，同时在信中强调政府不应止步于此。
“作为数十亿纳税人辛勤赚来的资金的守护者，我们支持劳工部的拟议规则，并希望政府能采取更进一步的行动，”犹他州州审计官蒂娜·坎农对福克斯新闻数字频道表示。
“执行价格透明度对于我们有效履行受托责任至关重要，”她说。“加强对雇主赞助的健康计划的监督和问责，将有助于防范联邦医疗保健项目中的浪费、欺诈和滥用行为，比如我的办公室去年在犹他州发现的4.637亿美元不当医院付款。扩大这项规则的适用范围将帮助我们履行职责、铲除欺诈和浪费，并降低所有美国人的医疗成本。”
信件指出，由药品福利管理机构驱动的“复杂网络”隐藏回扣、费用和激励措施，使得欺诈行为多年来未被发现。
参议院多数党领袖推动对每一分税收资金实行‘凭单报销’，此前明尼苏达州爆发欺诈丑闻
此次倡议此前数月，特朗普政府和州财务官员协会一直在采取行动打击各级政府的浪费、欺诈和滥用行为。特朗普最近任命副总统JD·万斯为美国“欺诈沙皇”，领导反欺诈工作组，而州财务官员协会在2月份发现了数十亿美元的纳税人资金浪费。
来自内布拉斯加州、路易斯安那州、怀俄明州、宾夕法尼亚州、西弗吉尼亚州、北达科他州、印第安纳州、俄克拉荷马州、南卡罗来纳州、犹他州、密西西比州和堪萨斯州的12个州的财务主管和审计官联名支持这项行动。
信件称，顶级药品福利管理机构每年截留超过500亿美元未披露的回扣和费用，这“阻碍了有效监督”。信件详细说明了这种隐藏欺诈的运作手段。
“美国的医疗服务超额收费推高了雇主（和患者）的成本，侵蚀了股东价值，”信件中写道。
万斯披露明尼阿波利斯市查获190亿美元欺诈案，暗示加州将是下一个目标
副总统JD·万斯召开新反欺诈工作组首次会议，指责拜登政府削弱了长期存在的保护措施。（希瑟·迪尔/盖蒂图片社摄）
一个主要担忧是，药品福利管理机构向配药药房收取更高的药品费用，“将差价或‘价差’作为利润留存”。反过来，对监管机构隐藏的资金推动了价格飙升。
信件还指出，药品福利管理机构以更高的回扣从制造商处购买更昂贵的药品，却从未披露这些激励措施。
“这些安排通常不会公开，因此计划赞助商往往无法了解药品福利管理机构在其处方集上实际为药品支付了多少费用，”信件中写道。
它补充称，药品福利管理机构引导患者远离更便宜的药房选择，转而选择自己旗下的药房，以提高利润。
信件显示，2023年美国医疗支出接近5万亿美元，约占GDP的17.6%，而2024年雇主支出约1.3万亿美元，成本每年上涨超过5%。
【点击此处下载福克斯新闻APP】
这封信是在这些官员近期向财富500强企业施压，要求其仔细审查医疗支出数据的基础上发出的，这标志着投资者推动的成本透明度运动日益壮大。
它还紧随州财务官员协会最近的一份报告发布，该报告显示，仅在2025年，财务官员就阻止了280亿美元的浪费和滥用行为，同时最新民调显示，美国人将欺诈视为生活成本上涨的主要驱动因素之一。
安德鲁·马克·米勒是福克斯新闻记者。可在推特@andymarkmiller关注他，或发送爆料邮件至AndrewMark.Miller@Fox.com。
Over a dozen state officials rally behind game-changing Trump admin rule cracking down on fraud: ‘Essential’
2026-04-15T13:23:38-04:00 / Fox News
The proposed rule would require full disclosure of hidden fees, conflicts of interest
By Andrew Mark Miller, Kiera McDonald, Fox News
Published April 15, 2026 1:23pm EDT
White House anti-fraud task force flags $6.3 billion in potential government fraud
White House Anti-Fraud Task Force Vice Chair Andrew Ferguson discusses the task force’s discovery of $6.3 billion in potential fraudulent government contracts, criticizing Democrat governors for allowing widespread fraud and even facilitating it for decades. Ferguson reveals examples of lavish spending by alleged fraudsters and highlights states like California and Hawaii’s failure to prosecute fraud despite receiving federal funds.
NEW You can now listen to Fox News articles!
Listen to this article
5 min
FIRST ON FOX:Financial officers from 12 states are backing a proposed Department of Labor rule that targets healthcare “middlemen” by demanding more transparency, rallying behind the Trump administration’s waste, fraud, and abuse crackdown as well as the goal of lowering healthcare costs.
In a letter to the Labor Department obtained by Fox News Digital, over a dozen state financial officers in the State Financial Officers Association (SFOF) offered their support of a proposed rule being evaluated by the Labor Department targeting pharmacy benefit managers (PBMs) that would expose hidden fees, conflicts of interest and overcharging that drive up costs.
“Healthcare purchasers are operating in the dark, paying inflated costs because hidden pricing and middlemen obscure where every dollar goes,” OJ Oleka, CEO of the State Financial Officers Foundation, told Fox News Digital. “By bringing those hidden prices into the light, companies can finally identify waste, negotiate better deals, and redirect those savings toward higher wages, more jobs, stronger benefits for workers, and increases to shareholder value.”
Oleka went on to explain that on a state level, the transparency brought on by the new rule is “essential to safeguarding taxpayer resources and fulfilling fiduciary responsibilities.”
LABOR DEPT DEPLOYS ‘STRIKE TEAM’ TO CALIFORNIA OVER $21B UNEMPLOYMENT DEBT, FRAUD CONCERNS
U.S. President Donald Trump waves to the media after walking off of Air Force One at Miami International Airport on April 11, 2026, in Miami, Florida.(Tasos Katopodis/Getty Images)
“Transparency isn’t just about accountability; it’s critical to detecting waste, preventing fraud, and ensuring that healthcare spending delivers value to the workers, businesses, and taxpayers who ultimately bear these costs.”
If implemented,the rule would require full disclosure of these “middlemen” revenue streams, expand beyond pharmacy benefit managers to insurers and third-party administrators, and allow access to claims and pricing data, which SFOF says will be a key tool in combating fraud while outlining in the letter that the administration shouldn’t stop there.
“As the guardians of billions of taxpayers’ hard-earned dollars, we support the Labor Department’s proposed rule and hope the administration goes even further,” Tina Cannon, Utah’s state auditor, told Fox News Digital.
“Enforcing price transparency is essential for us to perform our fiduciary duties effectively,” she said. “Greater oversight and accountability for employer-based health plans will help prevent waste, fraud, and abuse in federal healthcare programs, such as the $463.7 million in inappropriate hospital payments my office uncovered in Utah last year. Expanding this rule would help us do our jobs, root out fraud and waste, and reduce the cost of healthcare for all Americans.”
A “complex web” of hidden rebates, fees, and incentives, driven by pharmacy benefit managers, has allowed fraud to go undetected for years, according to the letter.
SENATE DOGE LEADER MOVES TO FORCE ‘RECEIPT’ FOR EVERY TAX DOLLAR AFTER MINNESOTA FRAUD SCANDAL
The push follows months of action from the Trump administration and SFOF to crack down on waste, fraud, and abuse across government. Trump recently named Vice President JD Vance the nation’s “fraud czar” to lead an anti-fraud task force, and in February the SFOF uncovered billions in taxpayer waste.
Treasurers and auditors from 12 states — including Nebraska, Louisiana, Wyoming, Pennsylvania, West Virginia, North Dakota, Indiana, Oklahoma, South Carolina, Utah, Mississippi and Kansas — signed onto the effort.
More than $50 billion annually in undisclosed rebates and fees is retained by top pharmacy benefit managers, which has “prevented effective oversight,” according to the letter. The letter details methods used to generate this hidden fraud.
“Healthcare overcharging in the United States erodes shareholder value by driving up costs for employers (and patients),” the letter states.
VANCE REVEALS $19B FRAUD UNCOVERED IN MINNEAPOLIS, HINTS CALIFORNIA IS NEXT TARGET
Vice President JD Vance convened the first meeting of a new anti-fraud task force, blaming the Biden administration for weakening longstanding protections.(Heather Diehl/Getty Images)
One major concern is that pharmacy benefit managers charge more for a drug than they pay at the dispensing pharmacy “to keep the difference or ‘spread’ as profit.” In turn, money hidden from regulators drives price spikes.
The letter also states that pharmacy benefit managers are buying more expensive drugs from manufacturers for higher rebates without those incentives ever being disclosed.
“These arrangements are generally not made public, so plan sponsors often do not have insight into how much pharmacy benefit managers are actually paying for drugs on their formularies,” according to the letter.
It adds that pharmacy benefit managers are steering patients away from cheaper pharmacy options to their own affiliated pharmacies to boost profits.
In 2023, U.S. healthcare spending reached nearly $5 trillion, about 17.6% of GDP, while employers spent roughly $1.3 trillion in 2024, with costs rising more than 5% annually, according to the letter.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The letter builds on recent pressure from these same officials on Fortune 500 companies to more closely examine healthcare spending data, signaling a growing investor-driven push for cost transparency.
It also follows a recent SFOF report showing that financial officers prevented $28 billion in waste and abuse in 2025 alone, along with new polling indicating that Americans view fraud as a major driver of rising living costs.
Andrew Mark Miller is a reporter at Fox News. Find him on Twitter @andymarkmiller and email tips to AndrewMark.Miller@Fox.com.
发表回复